Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients
Curcumin as add-on to Antipsychotic Treatment in Chronic Schizophrenia Patients: A Randomized, Double-Blind, Placebo-controlled Study
Sponsor: Beersheva Mental Health Center
A PHASE4 clinical study on Chronic Schizophrenia, this trial is completed. The trial is conducted by Beersheva Mental Health Center and has accumulated 8 data snapshots since 2015. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Feb 2019 — Jan 2021 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
-
Jun 2018 — Feb 2019 [monthly]
Unknown Status PHASE4
▶ Show 3 earlier versions
-
Feb 2018 — Jun 2018 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Feb 2017 — Feb 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Jan 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Beersheva Mental Health Center
- Tirat Carmel Mental Health Center
For direct contact, visit the study record on ClinicalTrials.gov .